tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts

3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Enovix (ENVX) – This is a U.S. battery technology company developing lithium-ion cells for next-generation portable and mobile devices. Yesterday, William Blair analyst Jed Dorsheimer maintained a Buy rating on the stock, citing its strong cash position and technology edge. He noted that the AI-1 battery is the top smartphone battery for energy density and could win premium pricing. Interestingly, six out of the seven Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 107.25%. 

Apogee Therapeutics (APGE) – Apogee Therapeutics is a biotech company developing antibody drugs for inflammatory and immune diseases. Yesterday, Bank of America Securities analyst Tim Anderson maintained a Buy rating on the stock and increased the price target to $87 from $78 per share. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 169.9%.

NexGen Energy (NXE) – NexGen Energy is a Canadian company focused on developing uranium projects. Yesterday, Raymond James analyst Brian MacArthur maintained a Buy rating on the stock and increased the price target to $9.07 from $7.34 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 40.46%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclaimer & DisclosureReport an Issue

1